Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare,…
| Métrica | HQL | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 51.1% | — |
| Operating Margin | — | 8.5% | — |
| Net Margin | — | 16.3% | — |
| FCF Margin | — | 19.6% | — |
| ROE | — | 9.6% | — |
| ROA | — | 1.1% | — |
| Current Ratio | — | 1.27 | — |
| Debt / Equity | — | 0.33 | — |
abrdn Life Sciences Investors cotiza a 18.74 USD y tiene una capitalización bursátil de $570M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Servicios financieros